Skip to the page

Data / Form D filings / Abacus Bioscience Inc.

Abacus Bioscience Inc.: Form D filing

Abacus Bioscience Inc., a company in Sammamish, WA, filed a Form D with the SEC in 2023. The latest, on February 3, 2023, reports $4.4 million sold of a $4.4 million offering to 13 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
27213 SE 27TH ST., Sammamish, WA, 98075
Phone
(425) 780-5613
Industry
Other
Entity type
Corporation
Incorporated in
Delaware
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1964311

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Feb 3, 2023New notice$4,413,591$4,413,59113Jan 19, 2023sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Jonathan DrachmanDirector
Alan WahlExecutive Officer, Director, Promoter
Will CanesteroDirector
Che-Leung LawDirector
Diane HollenbaughDirector

Other companies in Washington that filed recently

Every Form D from the week of Jan 30, 2023 · All recent filings in Washington · All recent Other filings

Read from SEC EDGAR. Amount sold is what Abacus Bioscience Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.